Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ZY

Zymergen (ZY) Stock Price, News & Analysis

Zymergen logo

About Zymergen Stock (NASDAQ:ZY)

Advanced Chart

Key Stats

Today's Range
$2.43
$2.43
50-Day Range
$2.35
$3.14
52-Week Range
$1.10
$12.42
Volume
85 shs
Average Volume
1.23 million shs
Market Capitalization
$253.58 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Zymergen Inc. design, develop, and commercialize microbes, molecules, and materials. It offers an automation solution comprising reconfigurable automation carts, a modular hardware building blocks that allow for assembly of work cells customized for the particular needs of a lab; and automation control software, a cloud-based software used to control integrated automation systems. It serves electronics, packaging, healthcare, agriculture, and other industries. Zymergen Inc. was incorporated in 2013 and is based in Emeryville, California. As of October 19, 2022, Zymergen Inc. operates as a subsidiary of Ginkgo Bioworks Holdings, Inc.

Receive ZY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zymergen and its competitors with MarketBeat's FREE daily newsletter.

ZY Stock News Headlines

Trump’s tariffs just split the AI market in two
Trump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying on cheap foreign hardware—just saw their costs shoot through the roof. For the other group of AI companies, they were just handed a massive competitive advantage. Make no mistake, AI as a whole is still a game-changer for the global economy. But within the AI sector, Trump’s tariffs have created a huge divergence.
Ginkgo Bioworks: Broken Narrative
See More Headlines

ZY Stock Analysis - Frequently Asked Questions

Zymergen (ZY) raised $401 million in an initial public offering on Thursday, April 22nd 2021. The company issued 13,600,000 shares at a price of $28.00-$31.00 per share. J.P. Morgan, Goldman Sachs, BofA Securities, Cowen, UBS Investment Bank and Lazard served as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Zymergen investors own include Tesla (TSLA), NIO (NIO), Meta Platforms (META), PayPal (PYPL), Snowflake (SNOW) and Teladoc Health (TDOC).

Company Calendar

Today
4/26/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Commercial physical research
Sub-Industry
N/A
Current Symbol
NASDAQ:ZY
Fax
N/A
Employees
502
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-361,790,000.00
Net Margins
-2,508.94%
Pretax Margin
-2,508.42%

Debt

Sales & Book Value

Annual Sales
$16.74 million
Price / Cash Flow
N/A
Book Value
$3.99 per share
Price / Book
0.61

Miscellaneous

Free Float
92,145,000
Market Cap
$253.58 million
Optionable
Not Optionable
Beta
1.69

Social Links

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (NASDAQ:ZY) was last updated on 4/26/2025 by MarketBeat.com Staff
From Our Partners